Older adults respond well to immunotherapy despite age-related immune system differences

Older adults with cancer respond just as well as younger patients to immune checkpoint inhibitors despite age-related immune system differences, according to a new study.

Older adults with cancer respond just as well as younger patients to immune checkpoint inhibitors despite age-related immune system differences, according to a new study.

Read more https://www.sciencedaily.com/releases/2025/04/250421163336.htm